• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RAYNER INTRAOCULAR LENSES LIMITED RAYONE EMV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RAYNER INTRAOCULAR LENSES LIMITED RAYONE EMV Back to Search Results
Model Number RAO200E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Red Eye(s) (2038)
Event Type  malfunction  
Manufacturer Narrative
The reference (b)(4) has been allocated to this case by rayner.The event description provided states that 8 days post iol implantation the patient presented with redness of the eye.The patient was prescribed antibiotics; however, their symptoms did not resolve.The patient was then prescriped methylprednisolone; however, this has also been unsuccessful in resolving their symptoms.Every batch of iols manufactured by rayner are tested for endotoxin and bioburden.Rayner's endotoxin acceptable tolerances are derived from bs en iso 11979-08 (2017) ophthalmic implants - intraocular lenses part 8 fundamental requirements.We have set our own limits for bioburden as there is no standard that prescribes acceptable limits.Batches are only released for distribution if the endotoxin and bioburden results are within tolerance of their respective limits which makes a rayner microbiological issue for these incidents of eye redness very unlikely.The cause of the post-operative redness of the eye has not been established.There is currently insufficient information available.No lot number has been provided to rayner to date.Rayner has requested additional information from its distributor in indonesia to facilitate further investigation of the event, including whether or not the healthcare facility uses reusable surgical instruments or single use instruments.
 
Event Description
On (b)(6) 2022, rayner intraocular lenses limited received notification from its indonesian distributor of an event that occurred following implantation of rayone emv rao200e.The event description provided states that 8 days post-operatively the patient presented with eye redness requiring medication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAYONE EMV
Type of Device
RAYONE
Manufacturer (Section D)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK  BN14 8AQ
Manufacturer (Section G)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK   BN14 8AQ
Manufacturer Contact
jodie neal
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 -8AQ
UK   BN14 8AQ
MDR Report Key15275357
MDR Text Key298620510
Report Number3012304651-2022-00052
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeID
PMA/PMN Number
P060011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 08/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberRAO200E
Device Catalogue NumberRAO200E
Device Lot NumberNOT AVAILABLE
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/15/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-